Merck Canada announces $2-million grant to support personalized treatment in cancer

At the 6th Annual National Conference to Defeat Cancer, organized by Coalition Priorité Cancer, Merck Canada reinforced the company’s continued commitment to the Quebec life sciences research innovation sector by announcing a $2-million grant to the Quebec – Consortium de recherche en oncologie clinique (Q-CROC).